Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Tag: Sugammadex

December 2, 2020 Pharma applications

Pillar[n]MaxQ: A New High Affinity Host Family for Sequestration in Water

Lyle Isaacs and his research team from the University of Maryland have further advanced the structure of the pillararenes to

Continue reading

May 8, 2020 CD derivatives / Drug delivery / Pharma applications

Chlorpromazine complexation with Sugammadex – an extremely high complexation constant

An in press paper on detailed ITC and NMR study of chlorpromazin complexation with various cyclodextrins reports on an unexpected

Continue reading

June 6, 2019 CD as API / CD derivatives / E-ducation

Carbohydrate drugs (Part 5) (Oligosaccharides, cyclodextrins)

First let’s talk about one of the biggest achievements in the history of cyclodextrin research: Sugammadex. Sugammadex (SGM) (BridionTM) (1a)

Continue reading

January 2, 2019 CD as API / CD derivatives / Cosmetics and toilettry / Drug delivery / Gene delivery / Non-pharma applications / Pharma applications

Cyclodextrin News Year in Review 2018

The CDNews blog was created in July and after a short period of trial it started in September. During this

Continue reading

November 22, 2018 Drug delivery / Pharma applications

Cyclodextrins involved in clinical trials to start

According to clinicaltrials.gov, currently, there are 14 cyclodextrin-related clinical trials that in the status of i) Not yet recruiting, ii)

Continue reading

November 13, 2018 Pharma applications

New Clinical Trial for Efficacy and Safety of Sugammadex in 0-2 Years Old Children

Federal Research Institute of Pediatric Hematology, Oncology and Immunology is about to launch a clinical study at Dmitry Rogachev National

Continue reading

September 6, 2018 E-ducation / Non-pharma applications / Pharma applications

Video-class on History of Cyclodextrins

Starting from the discovery of cyclodextrins (“cellulosines” at that time) by Villiers in 1891 the history of cyclodextrin research is

Continue reading

September 6, 2018 Drug delivery / Events / Pharma applications

Cyclodextrins at CPHI Worldwide

The biggest pharma exhibition in the world, CPHI Worldwide will be organized 9-11th October in Madrid. By joining (which is

Continue reading

August 29, 2018 CD as API / CD derivatives / Pharma applications

New process to make Sugammadex. Again…

A new patent application has just been published reporting and claiming a new process how to manufacture super-pure Sugammadex. This

Continue reading

August 28, 2018 Drug delivery / Pharma applications / Supramolecular systems

Cyclodextrins as theranostics

The application of cyclodextrins as excipients is wellspread, common knowledge worldwide. Their application as APIs is getting huge publicity, developments

Continue reading

Recent Posts

  • Roquette on the role of cyclodextrins in vaccines
  • CD-based Nanoparticles from CNR-ISMN Institute of Nanostructured Materials
  • Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for Filing of New Drug Application (NDA) for the Use of SBECD-enabled Ganaxolone in CDKL5 Deficiency Disorder (CDD)
  • Changes in the management of CycloLab
  • Dendrimer-based formulation of remdesivir

Tags

antiviral Betadex Sulfobutyl Ether Sodium Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems Drugs FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease Polymer RAMEB remdesivir SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (7)
  • Analysis (12)
  • CD as API (93)
  • CD derivatives (117)
  • Cosmetics and toilettry (10)
  • Drug delivery (181)
  • E-ducation (40)
  • Environmental (38)
  • Events (91)
  • Food (53)
  • Gene delivery (6)
  • In Hungarian (4)
  • Non-pharma applications (90)
  • Other industrial use (32)
  • Pharma applications (333)
  • Supramolecular systems (7)
  • Uncategorized (21)

Top Posts

  • Changes in the management of CycloLab
  • New cyclodextrin with orphan drug designation: SBECD
  • Remdesivir dry powder inhalation formulation, pharmacokinetic study in hamsters
  • Roquette on the role of cyclodextrins in vaccines
  • Cyclo Therapeutics Reports on Eighteen Month Expanded Access Program in Single Alzheimer’s Patient
  • Underdog Launches With $4M to Target “Toxic” Form of Cholesterol
  • Nasal delivery with beta-cyclodextrin is approved; a short story of Baqsimi
  • Results of HPBCD-enabled MTX110 Phase I Study
  • History of Cyclodextrin Nanosponges
  • CD-based Nanoparticles from CNR-ISMN Institute of Nanostructured Materials

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 278 other subscribers